Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines.
Sam de Costa
Advertisement
Articles by Sam de Costa
FDA approved the Raplixa, the first spray-dried fibrin sealant, in May 2015 to help control bleeding in adults during surgery.
Advertisement
Latest Updated Articles
Breaking the Cold Chain for VaccinesPublished: May 16th 2021 | Updated:
- Raplixa case study: Enabling an innovative drug presentation through aseptic spray drying
Published: July 2nd 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
AI and Human Collaboration Essential for Bio/pharma Innovation
4
Why Sound Science Is Pharma's Best Defense Against Regulatory Shifts
5
